Skip to search formSkip to main contentSkip to account menu

dexpramipexole

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Pramipexole

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Panch SR, Bozik ME, Brown T, et al. Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes. Blood. 2018;132(5):501-509.
  • Blood
  • 2018
  • Corpus ID: 52878958
2016
2016
Utilisation de r(+)-pramipexole (dexpramipexole) pour le traitement d'une ischémie focale cérébrale
L'invention concerne l'utilisation de (R)-N6-propyl -4,5,6,7-tetrahydrobenzo d] thiazole-2,6-diamine (dexpramipexole) dans la… 
2013
2013
Dexpramipexole Safe but Not Effective for ALS
Amyotrophic lateral sclerosis (ALS) is a progressive, ultimately fatal neurodegenerative disease for which effective treatments… 
2012
2012
Amyotrophic Lateral Sclerosis : Drug Therapy from the Bench to the Bedside Summer
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive muscular atrophy and weakness… 
2012
2012
Human Dopamine Receptor Affinity and Potency In Vitro and Dose Tolerability in Beagle Dogs In Vivo of Dexpramipexole and Pramipexole (P04.150)
Objective: To determine and quantify the relative dopamine receptor affinity and agonism of the optical enantiomers pramipexole… 
2012
2012
The EMPOWER Study: Design, Methodology and Baseline Features of the First Phase III Clinical Trial of Dexpramipexole for Patients with ALS (S25.004)
2011
2011
Dexpramipexole in ALS: Cautious Optimism
The only pharmacological agent proven to slow disease progression in amyotrophic lateral sclerosis (ALS) is riluzole, and its… 
2011
2011
Encouraging Phase 2 Results for Dexpramipexole for ALS Prompt Phase 3 Trial